>
Pathway To Citizenship For DACA? Trump Directs DHS Chief To 'Work With Democrats'...
Department Of Labor Floats Stricter Rules For Unemployment Benefits
Baby it's cold INSIDE! Scientists create the coldest temperature ever recorded in the lab...
Dark horse Jim Jordan beats establishment pick Steve Scalise to lead House GOP after promising...
Musk's Starlink Is Building An Orbital Bypass As Undersea Cable Sabotage Threats Mount
A robot just built a structure in space for the first time
The Greatest Theft in Human History
3D-Printed Tungsten Survives 74 Fusion Plasma Discharges, Advancing the Engineering...
Dude turns a $23 used smartphone into the 4G brain of an RC aircraft.
China's World-Beating Supercar Just Hit 312 MPH
Pentagon Delivers 25,000+ Drones And Counter-Drone Systems To CENTCOM In A "Massive Surge"
Prism puts an eye-controlled Linux computer on your face
Remember Yesterday: AI For Today and Tomorrow
Robot Mowers Invade America's Golf Courses, Putting Groundskeepers On Notice

This exciting new study shows that "proton therapy" is a stunningly effective noninvasive treatment against high-risk childhood cancers – and it comes with minimal side effects.
Unlike traditional photon radiation using x-rays, proton radiation therapy (PRT) is a non-invasive, precise cancer treatment that uses a beam of protons moving at very high speeds to destroy the DNA of cancer cells, killing them and preventing them from multiplying.
Highly targeted, PRT has significant promise for treating tumors in very young children and may reduce radiation exposure to healthy, developing tissue that may result in lifelong impacts.
Researchers from Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania analyzed the largest cohort to date of pediatric patients with high-risk neuroblastoma who were treated with proton radiation therapy.
Not only did they find that proton therapy was effective at reducing tumors, they also found that it demonstrated minimal toxicity to surrounding organs.
The study is published online in the International Journal of Radiation Oncology.
"These data are extremely encouraging and could be a game-changer for a number of reasons," said lead author Christine Hill-Kayser, Chief of the Pediatric Radiation Oncology Service at Penn Medicine.